Get straight answers on running AI within clinical trials safely. Access practical articles, deep-dive papers and videos on how to optimize your trials without introducing risk.
This webinar gives clinical trial teams a practical roadmap for bringing AI into operations responsibly, using a phased approach that builds the workflow foundation and compliance guardrails each stage of adoption requires.
AI in clinical trials keeps floating untethered — producing answers no one knows what to do with. In this SCOPE X session, AG Mednet CEO Abraham Gutman argues it only becomes deployable when trials run on an orchestrated execution layer that gives every decision and handoff a place to land.
Leverage Judi for increased compliance: expedited, high quality, structured decision-making on centralized patient eligibility determination that can eliminate an entire category of important protocol deviations from your trial
European-based biopharma and partner CRO employ dynamic controls of Judi in Adjudication and Site & User Qualification for rare disease immunotherapy trial with over 250 endpoints
International biopharma sponsor and partner CRO maximize flexibility of Judi in DSMB for Phase 2 multinational clinical program with over 100 patients and 60 sites
